Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Conversion of 938,979 LTGO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Latigo Biotherapeutics, Inc. (LTGO) | Conversion | 938,979 | n/a |
| Jun 15, 2026 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 39,567 | n/a |
| May 29, 2026 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 5,093 | n/a |
| May 26, 2026 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 17,084 | n/a |
| Dec 22, 2025 | Kyverna Therapeutics, Inc. (KYTX) | Purchase | 133,333 | $1000.0K |
| Jun 10, 2025 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 28,522 | n/a |
| Jun 2, 2025 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 16,634 | n/a |
| May 16, 2025 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 14,000 | n/a |
| Oct 30, 2024 | Vera Therapeutics, Inc. (VERA) | Sale | 14,798 | $710.5K |
| Sep 20, 2024 | Vera Therapeutics, Inc. (VERA) | Sale | 1,177 | $49.4K |